Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.5, 2011-05, pp. : 807-812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 354-367

Bentham Science Publishers

Access to resources Recommend Favorite

Pyrazolopyridines as inhibitors of the kinase LRRK2: a patent evaluation (WO2011141756)

By Deng Xianming S. Gray Nathanael

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 709-713

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2011134971, chiral 1,6-napthyridine Syk kinase inhibitors

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 335-339

Informa Healthcare

Access to resources Recommend Favorite

Selective urokinase inhibitors based on substituted aryl guanidines

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1975-1977

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2013117503 and WO2013117504: the use of PI3K inhibitors to treat cough or idiopathic pulmonary fibrosis

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 719-722

Informa Healthcare

Access to resources Recommend Favorite